TrialJournal of diabetes2014

Thiazolidinedione use is associated with improved all-cause mortality compared with sulfonylureas among diabetic hemodialysis patients.

Katherine E Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.